Position in TGTX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$9,912,848
+$1,053,316 QoQ
Shares Held
298,400
+0.4% QoQ
Ownership
0.195%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Swiss National Bank holds $1,641,068,484 across 148 Biotechnology names. TGTX ranks #25 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,600 | $332,493,684 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
303,140 | $234,218,089 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
387,720 | $128,284,916 | |
| 4 | INSM |
INSMED Inc
|
625,912 | $102,349,130 | |
| 5 | RPRX |
Royalty Pharma plc
|
1,191,100 | $57,137,067 | |
| 6 | INCY |
Incyte Corp
|
489,774 | $46,097,528 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
425,431 | $41,373,164 | |
| 8 | MRNA |
Moderna, Inc.
|
696,100 | $35,361,880 |
All Filings in TGTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,912,848 | 298,400 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $8,859,532 | 297,200 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $10,559,337 | 292,300 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $10,264,348 | 285,200 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $11,296,695 | 286,500 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $8,707,930 | 289,300 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $6,703,574 | 286,600 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $5,134,194 | 288,600 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $4,321,161 | 284,100 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $4,826,808 | 282,600 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,608,320 | 312,000 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $7,519,068 | 302,700 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $4,481,920 | 298,000 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $3,941,756 | 333,200 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $1,926,368 | 325,400 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,359,575 | 319,900 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $2,732,223 | 287,300 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $5,076,800 | 267,200 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $8,842,496 | 265,700 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $10,015,578 | 258,200 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $11,582,460 | 240,300 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $11,917,782 | 229,100 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $5,994,240 | 224,000 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $3,422,636 | 175,700 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $1,710,192 | 173,800 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||